Health Care & Wellness Committee advances seven health bills; one deferred

The Health Care & Wellness Committee met April 1 and reported six bills out of committee with due-pass recommendations, deferred one bill for further work, and adopted amendments on two measures that change contract-notice rules and strengthen disclosure for continuing care retirement communities.

The committee's action moved forward substitute Senate Bill 5239 (medical record retention), engrossed second substitute Senate Bill 5337 (certification requirement for memory care units), Senate Bill 5455 (Andy Hill Cancer Research Endowment updates), substitute Senate Bill 5493 (hospital price transparency aligned to federal rules as of Jan. 1, 2025), substitute Senate Bill 5579 (limits on public statements about potential contract terminations; amended), and substitute Senate Bill 5691 (registered continuing care retirement communities; amended). Substitute Senate Bill 5594 (biosimilar medications) was deferred for further work.

Votes at a glance

- Substitute Senate Bill 5239 (medical record retention): Reported out of committee with a due-pass recommendation; expedited voice vote announced as 19 ayes. No amendments were adopted.

- Engrossed second substitute Senate Bill 5337 (assisted living memory care certification): Reported out of committee with a due-pass recommendation; expedited voice vote announced as 19 ayes. No amendments were adopted.

- Senate Bill 5455 (Andy Hill Cancer Research Endowment changes): Reported out of committee with a due-pass recommendation; expedited voice vote announced as 19 ayes.

- Substitute Senate Bill 5493 (hospital price transparency aligned to federal rules as of Jan. 1, 2025): Reported out of committee with a due-pass recommendation; expedited voice vote announced as 19 ayes. Committee discussion emphasized aligning state reporting with federal standards and producing state-level data.

- Substitute Senate Bill 5579 (limits on public statements about potential contract terminations): Amended and reported out of committee with a do-pass-as-amended recommendation; expedited voice vote announced as 19 ayes. The committee adopted amendment H-2102.2, which was described as negotiated with stakeholders and clarifies exceptions, adds certain providers to the prohibitions, and sets template and contract-inclusion deadlines (see separate article for details).

- Substitute Senate Bill 5594 (biosimilar medications): Deferred to allow more work on provisions of the gross substitute; proponents asked for additional time to refine the bill.

- Substitute Senate Bill 5691 (registered continuing care retirement communities): Amended (Blake 250) and reported out of committee with a do-pass-as-amended recommendation after a recorded roll call of 15 ayes and 4 nays. The amendment requires registration applications to state whether residency agreements include entrance fees and whether those fees cover future care and services.

Why it matters

Collectively, the actions move multiple health policy changes forward toward further legislative steps. Several bills focus on consumer information and oversight—ranging from medical-record retention and hospital price transparency to disclosure and enforcement changes for continuing care retirement communities. One bill addressing biosimilars was deferred for additional stakeholder work.

Details and next steps

Committee members asked questions on several bills but took expedited voice votes for most measures. The committee recorded a roll-call vote for substitute Senate Bill 5691 after debate on civil enforcement under the Consumer Protection Act. Staff announced vote tallies where roll-call votes were not used; where the transcript provided only the tally, the article reports the announced result. Deferred bills will return for further consideration in subsequent committee work.